"Visit Rappahannock General Hospital in Kilmarnock, Virginia. Rappahannock General Hospital is one of the many Hospitals & Medical Centers locations at Bon Secours providing good help to those in need."

During the past decade, Rappahannock General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rappahannock General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 2 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "GOG Foundation" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rappahannock General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Rappahannock General Hospital" are "Breast Cancer" (1 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (1 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (1 trials), "Fallopian Tube Mucinous Adenocarcinoma" (1 trials) and "Fallopian Tube Serous Adenocarcinoma" (1 trials). Many other conditions were trialed in "Rappahannock General Hospital" in a lesser frequency.

Most popular intervention types in "Rappahannock General Hospital" are "Drug" (5 trials), "Biological" (3 trials), "Other" (2 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Laboratory Biomarker Analysis" (2 trials), "Quality-of-Life Assessment" (2 trials) and "Accelerated fractionation radiation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rappahannock General Hospital" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Rappahannock General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Rappahannock General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rappahannock General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".